Molecule Details
InChIKeyHGEYJZMMUGWEOT-UHFFFAOYSA-N
Compound NameRoxindole
Canonical SMILESOc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)17
Pfam Stratification Homologous
Avg pChEMBL7.9
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB19883
Drug NameRoxindole
CAS Number112192-04-8
Groups experimental
ATC Codes nan
DescriptionRoxindole is a small molecule drug. Roxindole has a monoisotopic molecular weight of 346.2 Da.

Categories: Alkaloids Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Dopamine Agents Dopamine Agonists Heterocyclic Compounds, Fused-Ring Indole Alkaloids Indoles Indolizidines Indolizines Neurotransmitter Agents Psychotropic Drugs
Cross-references: BindingDB: 50002173 ChEBI: 48558 CHEMBL431367 ZINC: ZINC000001548439
Target Activities (17)
Target Gene Organism Category Pfam pChEMBL Type Source
P35462 DRD3 Homo sapiens Human PF00001 9.4 Ki ChEMBL;BindingDB
P08908 HTR1A Homo sapiens Human PF00001 9.1 IC50 ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 8.9 Ki BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 8.8 Ki BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 8.6 Ki BindingDB
P35368 ADRA1B Homo sapiens Human PF00001 8.6 Ki BindingDB
P14416 DRD2 Homo sapiens Human PF00001 8.5 Ki BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 8.3 Ki BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 8.2 Ki BindingDB
P28223 HTR2A Homo sapiens Human PF00001 8.2 Ki BindingDB
P21917 DRD4 Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P41595 HTR2B Homo sapiens Human PF00001 7.5 Ki BindingDB
P28221 HTR1D Homo sapiens Human PF00001 7.2 Ki BindingDB
P21918 DRD5 Homo sapiens Human PF00001 6.7 Ki BindingDB
P28335 HTR2C Homo sapiens Human PF00001 6.5 Ki BindingDB
P21728 DRD1 Homo sapiens Human PF00001 6.3 Ki BindingDB
P07550 ADRB2 Homo sapiens Human PF00001 6.0 Ki BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P14416 DRD2 D(2) dopamine receptor inhibitor targets